subclonal mutations associated_with cancer
Evidence from:
primary |
all sources
Evidence (1 sources)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
(2013)
PMID:23396013
cited
subclonal drivers of progression or resistance... subclonal architecture of cancer
confidence: 0.93